
Vapotherm
Develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders.
Market cap
$13.5m
Enterprise value
$133m
Share price
$2.17 VAPO
Authorizing premium user...